Autres langues Ligand Pharmaceuticals Incorporated

Actions

LGND

US53220K5048

Marché Fermé - Nasdaq Autres places de cotation 21:59:40 04/06/2024			Varia. 5j.	Varia. 1 janv.
80,7 ^USD	-8,20 %		-6,14 %	+12,99 %

13/05	Un initié de Ligand Pharmaceuticals a vendu des actions pour une valeur de 830 449 $, selon un récent dépôt auprès de la SEC	MT
08/05	Mise à jour sectorielle : Les actions du secteur de la santé en baisse en fin d'après-midi	MT

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Ligand Pharmaceuticals Incorporated : First Quarter 2024 Presentation	04/06
Ligand to Participate in Upcoming Investor Conferences	23/05
Ligand Pharmaceuticals Insider Sold Shares Worth $830,449, According to a Recent SEC Filing	13/05
Sector Update: Health Care Stocks Softer Late Afternoon	08/05
Ligand Pharmaceuticals Shares Rise After Q1 Adjusted Earnings, Revenue Beat Views	08/05
Ligand: Q1 Earnings Snapshot	07/05
Earnings Flash (LGND) LIGAND PHARMACEUTICALS INCORPORATED Posts Q1 Revenue $31M, vs. Street Est of $27.9M	07/05
Earnings Flash (LGND) LIGAND PHARMACEUTICALS INCORPORATED Reports Q1 EPS $1.20, vs. Street Est of $0.83	07/05
Ligand Reports First Quarter 2024 Financial Results	07/05
Ligand Pharmaceuticals Incorporated Reports Earnings Results for the First Quarter Ended March 31, 2024	07/05
Ligand Pharmaceuticals Incorporated Reaffirms Earnings Guidance for the Year 2024	07/05
Sector Update: Health Care Stocks Stronger in Tuesday Afternoon Trading	07/05
Ligand Pharmaceuticals Investing in Agenus to Fund Development of Oncology Drug Candidates	07/05
Ligand and Agenus Enter Into $100 Million Royalty Financing Agreement	07/05
Ligand to Report First Quarter 2024 Financial Results on May 7, 2024	23/04
Ligand Pharmaceuticals Incorporated : Certificate of Incorporation/Bylaws - Form 8-K	19/04
Ligand Pharmaceuticals Announces New Topiramate Injection Data Presented at 9th London-Innsbruck Colloquium on Status Epilepticus and Acute Seizures Conference	08/04
Ligand Pharmaceuticals Incorporated Announces New Topiram Injection Data Presented At 9th London-Innsbruck Colloquium on Status Epilepticus and Acute Seizures Conference	08/04
Ligand Pharmaceuticals Announces Launch of Pelthos Therapeutics to Accelerate Commercialization of ZELSUVMI	04/04
Ligand Pharmaceuticals Announces Launch of Pelthos Therapeutics to Accelerate Commercialization of ZELSUVMI™	03/04

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Ligand Pharmaceuticals Incorporated

Actions

LGND

US53220K5048

Autres langues

Filtres